These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5083810)

  • 1. [Antigenic and immunogenic properties of tetanus toxoids purified on DEAE-cellulose].
    Zakgeĭm DA; Golshmid VK; Il'nitskaia EA; Popadenko RV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Oct; 49(10):119-22. PubMed ID: 5083810
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of purified tetanus toxin and toxoid.
    Raynaud M; Turpin A; Bizzini B
    Prog Immunobiol Stand; 1967; 3():244-7. PubMed ID: 4985511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gel filtration as a method of obtaining molecularly homogeneous bacterial toxins and anatoxins (a review of the literature)].
    Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):89-96. PubMed ID: 4616559
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigenic and immunogenic characteristics of fractions isolated on DEAE-cellulose from purified concentrated toxoids of Cl. oedematiens].
    Artemenko VD; Nenashev VP; Golshmid VK; Ushakova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Mar; 49(3):104-9. PubMed ID: 4622928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Properties of C1. perfringens toxoids obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production.
    Behrensdorf-Nicol HA; Bonifas U; Hanschmann KM; Krämer B; Weißer K
    Vaccine; 2013 Dec; 31(52):6247-53. PubMed ID: 24156922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunogenic and antigenic properties of the individual fractions of tetanus anatoxin].
    Runova VF; Kargina TM; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):75-6. PubMed ID: 7879554
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids.
    Relyveld EH; Bizzini B; Gupta RK
    Vaccine; 1998; 16(9-10):1016-23. PubMed ID: 9682353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and immunogenic studies on purified tetanus toxoid.
    Nielsen PA; Ablondi FB; Querry MV; Gussoni C; Cooper MS
    J Immunol; 1967 Jun; 98(6):1248-56. PubMed ID: 4961126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Separation of the toxic component of incompletely detoxified tetanus toxin on DEAE-cellulose].
    Golshmid VK; Zakgeĭm DA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):109-13. PubMed ID: 5132803
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunochemistry of toxins and toxoids; the preparation and immunologic evaluation of purified tetanol toxoid.
    PILLEMER L; GROSSBERG DB; WITTLER RG
    J Immunol; 1946 Nov; 54(3):213-24. PubMed ID: 21001438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sensitizing properties of tetanus toxoid fractions separated by ion-exchange chromatography].
    Neprina GS; Medunitsyn NV; Golshmid VK
    Biull Eksp Biol Med; 1972 Aug; 73(8):70-3. PubMed ID: 4635289
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparative trial of standard (commercial) and antibody-affinity-purified tetanus toxoid vaccines.
    Leen CL; Barclay GR; McClelland DB; Shepherd WM; Langford DT
    J Infect; 1987 Mar; 14(2):119-24. PubMed ID: 3553336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 15. [Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation].
    Akama K; Yamamoto A
    Nihon Saikingaku Zasshi; 1969 Nov; 24(11):595-601. PubMed ID: 5391905
    [No Abstract]   [Full Text] [Related]  

  • 16. [An evaluation of the quality of tetanus anatoxins by gel electrophoresis].
    Runova VF; Kargina TM; Rezepov FF; Selezneva VP; Legat EM; Plotnikova VL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):38-40. PubMed ID: 1441810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenic property of tetanus anatoxins of various degrees of purity and polymerization].
    Bizzini B; Turpin A; Raynaud M
    Ann Inst Pasteur (Paris); 1971 Jun; 120(6):791-9. PubMed ID: 4997517
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative estimation of diphtheria and tetanus toxoids. 5. Comparative assays in mice and in guinea-pigs of two diphtheria toxoid preparations.
    Lyng J; Heron I
    Biologicals; 1991 Oct; 19(4):327-34. PubMed ID: 1797044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EFFECT OF TOXOIDS ON THE IMMUNOGENIC VALUE OF THE PERTUSSIS COMPONENT].
    TUROWSKI G
    Med Dosw Mikrobiol; 1963; 15():331-5. PubMed ID: 14118921
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunopurification of tetanus toxoid.
    Hughes M; Thomson RO; Knight P; Stephen J
    J Appl Bacteriol; 1974 Dec; 37(4):603-21. PubMed ID: 4215786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.